Overview

Efficacy of Erenumab on Functional Impact of Migraine

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy of erenumab on functional impact due to Migraine in adults.
Phase:
Phase 4
Details
Lead Sponsor:
Merle Diamond
Collaborators:
Clinvest Research, LLC
Smith, Timothy R., M.D.
Treatments:
Erenumab